Frank Deluccia is a director in the Valuation Advisory Services practice and part of the Healthcare and Life Sciences (HLS) industry group, based in the Morristown office. Frank leverages over 15 years of valuation experience assisting clients in the pharmaceutical, financial services, consumer products, non-profit and industrial products sectors.
As part of the HLS group, Frank has extensive experience in providing valuation services to integrated pharmaceutical companies, early stage biotech and medical device companies. Frank also has significant knowledge in business valuation, the valuation of intangible assets and the valuation of loan portfolios. He has performed business enterprise valuations for variety of strategic and transactional purposes, and for financial reporting and tax structuring purposes. Frank has determined the fair value of illiquid investments of private equity and hedge fund clients, and has worked with numerous joint ventures to determine the contribution of each party.
Frank received a B.S. in management from Boston College's Wallace E. Carroll School of Management with concentrations in finance and accounting.
Valuation
Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.
Tax Services
Built upon the foundation of its renowned valuation business, Kroll's Tax Service practice follows a detailed and responsive approach to capturing value for clients.